We are live on
!
Find out more
TM
Taproot Management Portfolio holdings
AUM
$530M
This Fund
S&P 500
This Quarter
Est. Return
+0.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$530M
AUM Growth
-$87.6M
(-14%)
Cap. Flow
-$76.4M
Cap. Flow
% of AUM
-14.42%
Top 10 Holdings %
Top 10 Hldgs %
16.44%
Holding
243
New
96
Increased
35
Reduced
49
Closed
63
Avg Time Held
0.5
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVB
AvalonBay Communities
AVB
|
+$8.86M |
| 2 |
AbbVie
ABBV
|
+$8M |
| 3 |
Abbott
ABT
|
+$7.95M |
| 4 |
Coca-Cola
KO
|
+$7.75M |
| 5 |
Elevance Health
ELV
|
+$7.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$11.3M |
| 2 |
Sanofi
SNY
|
+$10.2M |
| 3 |
Medtronic
MDT
|
+$10.2M |
| 4 |
Factset
FDS
|
+$9.91M |
| 5 |
GE Vernova
GEV
|
+$9.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.6% |
| 2 | Industrials | 20.75% |
| 3 | Consumer Discretionary | 16.07% |
| 4 | Consumer Staples | 12.4% |
| 5 | Real Estate | 11.75% |
Similar funds
FGAM
BFIC
AIM
OCM
JHCP
OWM
DCM
FFWA
Taproot Management's Q1 2026 Portfolio in Review
As of Q1 2026, Taproot Management held 243 positions worth $530M, down 14% from $617M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Taproot Management withdrew a net $76.4M in Q1 2026, closing 63 positions and reducing 49 holdings. Its most notable exit was Boston Scientific, an estimated $11.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Taproot Management opened a new position in AbbVie worth $7.85M.
- Taproot Management's largest Q1 2026 buy was AbbVie: 36,080 shares worth $7.85M.
- Taproot Management added most to AvalonBay Communities in Q1 2026, an estimated $8.86M increase.
- Taproot Management's biggest Q1 2026 reduction was Jabil, cutting an estimated $9.26M.
- Taproot Management fully exited Boston Scientific in Q1 2026, selling an estimated $11.3M.
- Taproot Management's ten largest holdings make up 16% of its $530M portfolio in Q1 2026.
- Taproot Management opened 96 new positions and closed 63 in Q1 2026.
- Taproot Management's portfolio value fell 14% quarter-over-quarter to $530M.
Based on Taproot Management's 13F filing for Q1 2026, filed 13 May 2026.